1、 It is mainly to carry out international new drug innovation and new drug research and development.

2、 Provide project evaluation services for biomedical investors to control risks.

3、 Provide validation and evaluation for national new drug evaluation.

Among them, the drugs for the treatment of rare diseases with abnormal lipid metabolism in the world will obtain the national production approval.